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ABSTRACT
To investigate the metabolic changes in the adipose 
tissue (AT) of dairy cows under milk fat depression 
(MFD), 30 cows were randomly allocated to a control 
diet, a conjugated linoleic acid (CLA)-supplemented 
diet, or a high-starch diet supplemented with a mixture 
of sunflower and fish oil (2:1; as HSO diet) from 1 to 
112 d in milk. Performance of animals, milk yield, milk 
composition, energy balance, and blood metabolites 
were measured during lactation. Quantitative PCR 
analyses were conducted on the AT samples collected 
at wk 3 and 15 of lactation. The CLA and HSO di-
ets considerably depressed milk fat yield and milk fat 
content at both wk 3 and 15 in the absence of signifi-
cant changes in milk protein and lactose contents. In 
addition, the HSO diet lowered milk yield at wk 15 
and decreased dry matter intake of cows from wk 3 to 
15. Compared with the control, both CLA and HSO 
groups showed reduced body weight loss, improved 
energy balance, and decreased plasma concentrations 
of nonesterified fatty acids and β-hydroxybutyrate at 
early lactation. The gene expression analyses reflected 
suppressed lipolysis in AT of the CLA and HSO groups 
compared with the control at wk 3, as suggested by 
the downregulation of hormone-sensitive lipase and 
fatty acid binding protein 4 and the upregulation of 
perilipin 2. In addition, the HSO diet promoted lipo-
genesis in AT at wk 15 through the upregulation of 
1-acylglycerol-3-phosphate O-acyltransferase 2, mito-
chondrial glycerol-3-phosphate acyltransferase, per-
ilipin 2, and peroxisome proliferator-activated receptor 
γ. The CLA diet likely regulated insulin sensitivity in 
AT as it upregulated the transcription of various genes 
involved in insulin signaling, inflammatory responses, 
and ceramide metabolism, including protein kinase B2, 
nuclear factor κ B1, toll-like receptor 4, caveolin 1, ser-
ine palmitoyltransferase long chain base subunit 1, and 
N-acylsphingosine amidohydrolase 1. In contrast, the 
HSO diet resulted in little or no change in the pathways 
relevant to insulin sensitivity. In conclusion, the CLA 
and HSO diets induced a shift in energy partitioning 
toward AT instead of mammary gland during lactation 
through the regulation of different pathways.
Key words: milk fat depression, lipolysis, insulin 
resistance, gene expression, ceramide
INTRODUCTION
High-producing dairy cows undergo negative energy 
balance (NEB) during the early stage of lactation due 
to insufficient DMI and the increasing nutrient require-
ment for lactation (Drackley et al., 2005). Adaptation 
to NEB may increase the risk of metabolic disorders, 
resulting from excessive mobilization of nutrients from 
body reserves (Ingvartsen, 2006). The NEB at early 
lactation can be attenuated by milk fat depression 
(MFD), as fat serves as the major energy component 
in milk (Moore et al., 2004). The MFD can be induced 
by dietary managements, for instance, by increasing the 
dietary concentrate/forage ratio, by increasing dietary 
starch level, or by dietary PUFA supplement (Kalscheur 
et al., 1997; Shingfield et al., 2006; Piccioli-Cappelli et 
al., 2014). Dietary starch level varies with the grain 
composition and therefore can be increased, for in-
stance, by replacing barley with wheat (Bernard et al., 
2016). A feeding strategy combining high starch level 
and PUFA supplement was found to effectively depress 
milk fat content (Zened et al., 2012). These MFD diets 
modify the ruminal biohydrogenation and increase the 
production of trans fatty acids that inhibit mammary 
lipogenesis (Shingfield et al., 2010; Ventto et al., 2017). 
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Of these trans fatty acids, trans-10,cis-12 CLA is the 
only isomer whose role in MFD has been clearly es-
tablished (Baumgard et al., 2000). Cis-9,trans-11 CLA 
is another CLA isomer that is often used in mixture 
with trans-10,cis-12 CLA because industrial synthesis 
results in a 1:1 mix of both isomers. However, evidence 
has been found suggesting that cis-9,trans-11 CLA 
has no effect on milk fat synthesis (Baumgard et al., 
2000). The mechanisms underlying the MFD induced 
by trans-10,cis-12 CLA include the coordinated reduc-
tion in the expression of various lipogenic genes in 
the mammary gland (Harvatine and Bauman, 2006; 
Gervais et al., 2009). In addition, trans-10,cis-12 CLA 
treatment and other milk fat depression diets also influ-
ence the metabolism in nonmammary tissues, for in-
stance, increase the expression of lipogenic genes of the 
adipose tissue (AT) during mid lactation (Harvatine 
et al., 2009; Thering et al., 2009). The coordination of 
metabolic changes in different tissues results in nutrient 
partitioning toward nonmammary tissues, particularly 
AT (Shingfield et al., 2010). During the periparturi-
ent period, nutrient partitioning is partly regulated by 
naturally occurring maternal insulin resistance (IR), 
which induces increased lipolysis and decreased lipo-
genesis in AT and thus leads to the mobilization of 
body fat reserves (Rico et al., 2015; Selim et al., 2015). 
Human and rodent studies suggest that IR in AT is 
affected differently by CLA isomers. Trans-10,cis-12 
CLA was reported to reduce triglyceride (TG) stores 
in adipocytes by increasing IR (Kennedy et al., 2009), 
whereas cis-9,trans-11 CLA was claimed to have anti-
diabetic effects (Moloney et al., 2007).
Insulin resistance is triggered by ceramide, a sphin-
golipid abundant in cell membrane that blocks phos-
phoinositide 3-kinase (PI3K) insulin signaling pathway 
in rodents (Chavez et al., 2003). Moreover, IR is asso-
ciated with SFA-induced inflammatory signaling that 
promotes the synthesis of ceramides (Chavez and Sum-
mers, 2012). In dairy cows, the mechanisms underlying 
IR remain uncertain. However, evidence has suggested 
that IR is associated with increased plasma, hepatic, 
and AT ceramide concentrations (Qin et al., 2017; Rico 
et al., 2017) and with upregulated inflammatory re-
sponses at gene expression level (Vailati-Riboni et al., 
2016).
In the present study, we aimed to induce MFD in 
dairy cows by either applying dietary rumen-protected 
CLA supplement or a high-starch diet with PUFA sup-
plement and investigate the effects of these diets on the 
lipid metabolism in AT. We hypothesized that these 
diets promote lipogenesis and inhibit lipolysis in AT 
during early lactation through the regulation of IR and 
the IR-related inflammatory responses and ceramide 
metabolism pathways.
MATERIALS AND METHODS
Animals, Experimental Design, and Diets
The National Ethics Committee (ESAVI/ 
4997/04.10.03/2012, Hämeenlinna, Finland) approved 
all experimental procedures in accordance with the 
guidelines established by the European Community 
Council Directives 86/609/EEC (European Council, 
1986). Thirty multiparous Nordic Red dairy cows of 
792 ± 72 kg (mean ± SD) BW during the last 2 wk 
before calving and 2.9 ± 1.0 (mean ± SD) parity were 
recruited from 28 d before expected calving until 112 
d postpartum but received the experimental diets only 
after calving. Cows were assigned to the diet groups to 
be comparable according to parity, BCS, BW, and Nor-
dic total merit (http:// www .nordicebv .info/ ntm -nordic 
-total -merit -2). Cows were housed in an experimental 
barn with a loose housing system, had free access to 
water and salt block, and were milked twice daily at 
0700 and 1645 h.
During the transition period, cows were offered a 
standard prepartum concentrate supplement (Supple-
mental Table S1; https:// doi .org/ 10 .3168/ jds .2017 
-14298). Treatments comprised a basal diet based on 
grass silage (CON), the same basal diet supplemented 
with CLA supplement (CLA diet/group), or a grass 
silage-based diet containing high-starch concentrate 
and supplemented with 40 g/kg of DM of a mixture of 
sunflower oil (EBM Grupp AS, Tallinn, Estonia) and 
fish oil (BASF, Ludwigshafen, Germany) in a 2:1 ratio 
(wt/wt) to induce MFD (HSO; Table 1). The CLA 
and HSO diets were formulated to induce a decrease 
in milk fat content during the first 112 d of lactation. 
The forage was restrictively fermented grass silage 
prepared from primary growth of mixed timothy (Ph-
leum pratense) and meadow fescue (Festuca pratensis) 
swards, grown at Jokioinen (60°49′N, 23°28′E) treated 
with a formic acid-based ensiling additive (5 L per t, 
AIV 2 Plus, Valio Ltd., Finland). The CLA supplement 
was given as rumen-protected lipid encapsulate (780 g 
of fatty acids/kg), containing both cis-9,trans-11 and 
trans-10,cis-12 isomers. Both CLA isomers were pres-
ent at 100 g/kg of supplement (Lutrell Pure, BASF, 
Ludwigshafen, Germany). Higher doses of CLA were 
used in early lactation to overcome the lower sensitivity 
of the mammary gland to CLA (Moore et al., 2004). 
Supplementation levels were 150 g/d during 1 to 14 
DIM, 125 g/d during 15 to 21 DIM, and 100 g/d from 
22 DIM to the end of study which resulted in providing 
15.0, 12.5, and 10.0 g of each isomer per day.
The diets were offered as a TMR with a forage: 
concentrate ratio of 55:45 on DM basis and were formu-
lated to be iso-nitrogenous. The CLA supplement was 
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top dressed and administered in 2 equal proportions at 
0630 and 1830 h on a daily basis. Oil supplements re-
placed concentrate ingredients in HSO diet. The TMR 
were fed as 4 meals at 0630, 1300, 1600, and 1830 h. 
Experimental diets were offered ad libitum to result in 
5% refusals and formulated to meet or exceed require-
ments for ME and MP (Natural Resources Institute 
Finland, 2015).
Measurements and Chemical Analysis
Measurements of energy balance (EB) were con-
ducted over a 4-d period after 1 d acclimatization 
starting on average 14 d postpartum and were repeated 
at 28-d intervals (wk 3, 7, 11, and 15) using indirect 
open-circuit respiration chambers. Feed intake and the 
output of feces, urine, and milk were measured in respi-
ration chambers or dedicated metabolic units during 4 
d of each EB measurement period. In addition, gaseous 
exchanges for cows entering the respiration chambers 
were measured during this period. The energy metabo-
lism of half of the cows was assessed using respiration 
chambers, whereas that of the rest of the cows was 
estimated based on the total fecal and urinary collec-
tion assuming the same partitioning of gross energy for 
methane production as their counterparts.
Daily feed intake and milk yield were measured daily, 
but only the data during EB measurement period were 
involved in statistical analysis. Body weight was mea-
sured before morning and afternoon feeding throughout 
the experiment. The BW recorded during 3 consecutive 
days before and after EB measurement periods were av-
eraged before statistical analysis to minimize the daily 
variation. Silage and concentrate samples were collect-
ed on a weekly basis and stored frozen (−20°C) until 
chemical analysis following the procedures described by 
Shingfield et al. (2002). Representative samples of the 
CON and HSO diets were collected for DM measure-
ments. Representative feces and urine sub-samples (50 
g/kg) were collected daily and stored at 4°C. At the end 
of each EB measurement period, sub-samples of feces 
and urine were composited and submitted for gross 
energy, DM, and nitrogen measurements. In addition, 
fecal samples were analyzed for ash, NDF, and starch 
using the procedures described by Shingfield et al. 
(2002). Gross energy of feed, fecal, and urinary samples 
was determined by bomb calorimetry (1108 Oxygen 
bomb, Parr Instrument, Moline, IL). Samples of morn-
ing and afternoon milk were collected daily during EB 
measurements, preserved with Bronopol tablets (Valio 
Ltd., Helsinki, Finland), and stored at 4°C until the 
determination of fat, CP, and lactose contents by infra-
red analysis (MilkoScan 133B, Foss Electric, Hillerød, 
Denmark). The somatic cell count of milk was recorded 
monthly for the first 5 mo of lactation (Fossomatic ana-
lyzer, Foss Electric, Hillerød, Denmark).
Blood samples were collected from a jugular vein into 
vacuum tubes containing sodium heparin or EDTA or 
into serum tubes at 1200 h on the last day of EB mea-
surement period and at 0600 h on 1 d after each EB 
measurement period. Plasma and serum were recovered 
by centrifugation at 2,083 × g for 15 min at 4°C, frozen 
immediately at −20°C, composited across sampling 
times for each cow, and stored at −80°C. Commercial 
routine analyses of blood concentrations of IGF-1, so-
matotropin, and leptin were performed on EDTA plas-
ma samples (Laboklin GmbH & Co., Helsinki, Finland). 
Analysis of blood insulin concentration was performed 
on serum samples using the RIA kit (PI-12K, Millipore 
Oy, Espoo, Finland), following the protocol described 
by Salin et al. (2012). Metabolic biomarkers in blood 
including glucose, cholesterol, TG, BHB, nonesterified 
fatty acids (NEFA), total bilirubin, haptoglobin, and 
ceruloplasmin were analyzed from plasma samples us-
ing the methods described by Piccioli-Cappelli et al. 
(2014) and Calamari et al. (2016).
Table 1. Formulation and ingredient composition of experimental 
diets1
Item CON HSO
Feed ingredient (g/kg of DM)  
 Grass silage2 550 550
 Rolled barley 210 69
 Ground wheat 0 209
 Molassed sugar beet pulp 55 0
 Barley feed 55 0
 Solvent-extracted rapeseed meal 115 115
 Urea 0 2
 Mixture of UFA3 0 40
 Vitamin and mineral premix4 15 15
Chemical composition (g/kg of DM unless stated)
 DM (g/kg as fed) 548 551
 OM 925 930
 CP 159 157
 NDF 379 333
 Water-soluble carbohydrate 43.8 37.1
 Starch 164 202
 Gross energy (MJ/kg of DM) 18.0 18.8
1CON = control diet; HSO = high-starch diet supplemented with sun-
flower and fish oil (2:1).
2Mean fermentation characteristics of experimental silage: pH, 3.98; 
in DM (g/kg) lactic acid, 56.4; acetic acid, 20.6; propionic acid, 0.49; 
butyric acid, 0.56; soluble N (g/kg of total N), 514; ammonium N (g/
kg of total N), 39.1; gross energy (MJ/kg of DM), 17.67.
3Containing sunflower and fish oils (2:1, wt/wt).
4Declared as containing (g/kg) calcium (190), magnesium (60), sodium 
(135), zinc (2.19), manganese (0.45), copper (0.40); (mg/kg) iodine 
(55), cobalt (35), selenium (30), and dl-tocopheryl acetate (550); (IU/
kg) retinyl acetate (220,000) and cholecalciferol (40,000); Onni, Melica 
Finland Ltd., Vaasa, Finland.
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Collection of Adipose Samples, RNA Extraction,  
and cDNA Synthesis
Subcutaneous AT samples were collected after morn-
ing milking on 2 d after the EB measurement period at 
wk 3 and 15. Biopsy samples were obtained from the 
subcutaneous fat in the ischiorectal fossa region, several 
centimeters caudally from the sacrotuberous ligament. 
Cows were sedated with xylazine (0.05 mg/kg intra-
venously, Narcoxyl 20 mg/mL, Intervet International 
B.V., Boxmeer, the Netherlands) and local anesthesia 
was induced with 100 mg of lidocaine (Lidocaine 20 
mg/mL, Orion Corporation, Espoo, Finland) injected 
subcutaneously. The biopsy site was shaved and cleaned 
using Betadine solution and ethanol. Approximately 2 
g of tissue was obtained through a 1-cm skin incision 
using a Weil-Blakesley rongeur (Braun Medical Oy, 
Helsinki, Finland). No suturing was made nor antibiot-
ics given. The samples were immediately immersed in 
RNA stabilization reagent (RNAlater, Qiagen, Hilden, 
Germany), stored at 4°C overnight, and stored at −80°C 
until RNA extraction after removal from RNALater 
solution.
Total RNA was extracted from frozen AT samples 
using RNeasy Lipid Tissue Mini Kit (Qiagen) following 
the method described by Selim et al. (2014). The con-
centration of total RNA solutions was measured with 
a NanoDrop ND-1000 spectrophotometer (NanoDrop 
Technologies, Wilmington, DE) based on the absor-
bance of the solution at 260 and 280 nm. The average 
260/280 absorbance ratio of total RNA samples was 
1.81 ± 0.13 (mean ± SD). Chip electrophoreses were 
performed on total RNA solutions with Agilent Bio-
analyzer 2100 chip electrophoresis system using Agi-
lent RNA 6000 Nano Kit following the manufacturer’s 
protocol (Agilent Technologies, Santa Clara, CA). The 
quality of RNA solutions were evaluated based on RNA 
integrity numbers and electropherograms. All the to-
tal RNA samples had adequate quality for the further 
analyses and showed average RNA integrity number of 
6.92 ± 0.60 (mean ± SD). The first-strand cDNA was 
synthesized from the total RNA solution with Roche 
cDNA First Strand Synthesis Kit (Roche Diagnostics, 
Mannheim, Germany), using the method described by 
Selim et al. (2014).
Primer Design and Real-Time PCR
Primers for 28 AT candidate genes were designed with 
online Primer3 Plus program (Whitehead Institute for 
Biomedical Research, Cambridge, MA; Rozen and Ska-
letsky, 2000; Supplemental Table S2, https:// doi .org/ 
10 .3168/ jds .2017 -14298). The uniqueness of primer 
sequences was inspected with the BLAST search tool 
and the GenBank sequence database of National Cen-
ter for Biotechnology Information. All oligonucleotides 
for real-time (RT) PCR were commercially synthesized 
and purified by reverse phase cartridge (Oligomer, Hel-
sinki, Finland). The RT-PCR analyses were performed 
in triplicates for each gene in one sample with LightCy-
cler 480 (Roche Diagnostics). Each reaction contained 
2.5 µL of 1:8 diluted cDNA solution, 5 µL of Roche’s 
2× master mix, 0.5 µL of each forward and reverse 
primer (5 pmol/µL), and 1.5 µL of DNase/RNase-free 
water. The temperature program of RT-PCR included 
an initial denaturation at 95°C for 5 min and 45 ampli-
fication cycles at 95°C for 20 s, at 60°C for 20 s, and at 
72°C for 20 s. A melting curve analysis was executed at 
the end of the PCR program.
The raw data from Lightcycler 480 was normalized 
with LinRegPCR (Heart Failure Research Center, 
Amsterdam, the Netherlands; Ruijter et al., 2009). 
The software performed the baseline correction for 
each reaction and calculated amplification efficiency of 
each reaction through the determination of window-of-
linearity and further linear regression analysis based 
on the window-of-linearity. The initial expression level 
(N0) and cycle threshold in each reaction was calculat-
ed using the mean efficiency (Supplemental Table S2; 
https:// doi .org/ 10 .3168/ jds .2017 -14298) and the cor-
rected baseline. Eukaryotic translation initiation factor 
3, subunit K (EIF3K), hippocalcin-like 1 (HPCAL1), 
and mitochondrial ribosomal protein L39 (MRPL39) 
were chosen as internal control genes in RT-PCR 
analyses based on previous publications (Saremi et al., 
2014; Vahmani et al., 2014). Their stability was evalu-
ated with Normfinder algorithm in R program based 
on the cycle threshold values obtained from RT-PCR 
involving all 90 cDNA samples (Andersen et al., 2004). 
EIF3K, HPCAL1, and MRPL39 showed stability given 
by Normfinder of 0.104, 0.123, and 0.115, respectively.
Calculations and Statistical Analysis
The chemical composition of TMR was calculated 
based on that of individual feed ingredients (Table 1). 
Energy intake and energy excretion in feces or urine 
were calculated by multiplying feed or excreta DM by 
their respective gross energy contents. The ECM was 
calculated based on the yields of fat, CP, and lactose 
{ECM (kg/d) = milk (kg/d) × [38.3 × fat (g/kg) + 
24.2 × protein (g/kg) + 16.54 × lactose (g/kg) + 
20.7]/3,140}. Methane energy was calculated using the 
conversion factor 55.24 kJ/g. The ME input of cows 
was calculated using the formula MEinput = gross energy 
− feces energy − urine energy − methane energy (all 
in MJ/d). The ME requirement of cows was calculated 
using the formula MEreq (MJ/d) = BW
0.75 (kg) × 0.515 
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+ 5.15 × ECM (kg/d) (Natural Resources Institute 
Finland, 2015). The EB was calculated by subtracting 
MEreq from MEinput.
All statistical analyses were performed in SAS (re-
lease 9.3, SAS Institute Inc., Cary, NC). The relative 
expression levels of candidate genes to internal control 
genes were calculated (i.e., the ratio of the N0 of one 
candidate gene to the geometric mean of the N0 of 
EIF3K, HPCAL1, and MRPL39). The relative expres-
sion levels were log2-transformed before statistical 
analysis. The analysis of other data was conducted on 
the original values. The box-and-whisker plots were 
composed for all variables, grouped by diet and time. 
The observations out of the whiskers range in plots 
were considered as outliers and were removed from the 
further analyses (Pupovac and Petrovecki, 2011). The 
normality of all the variables was tested with PROC 
UNIVARIATE on the residuals obtained from PROC 
MIXED using diet, time, and their interaction as fixed 
effects. Repeated-measures ANOVA was performed on 
all the variables except for BW and EB, using PROC 
MIXED with Tukey test and covariance structure of 
compound symmetry (CS), in which diet, time, and 
their interaction were set as fixed effects and animal was 
set as within-subject effect. The analysis of BW from 
wk 3 to 15 was performed using PROC MIXED with 
Tukey’s test and covariance structure of autoregressive 
covariance structure AR(1), in which diet, time, and 
their interaction were set as fixed effects, animal was 
set as within-subject effect, and BW at wk 1 was set as 
covariate. The analysis of EB from wk 3 to 15 was per-
formed in a 3-way ANOVA, using PROC MIXED with 
Tukey’s test and autoregressive covariance structure 
AR(1), in which diet, time, EB calculation method, 
and the interactions between EB calculation method, 
time, and diet were set as fixed effects, animal was 
set as within-subject effect. Nonsignificant interactions 
between time and EB calculation method were dropped 
from the final model. P ≤ 0.05 was considered to be 
statistically significant, and 0.05 < P < 0.10 was con-
sidered as a tendency toward significance.
RESULTS
Milk Yield and Composition
The CLA and HSO diets altered milk production 
and the contents of various milk components (Table 
2). The milk yields were similar in all the 3 groups at 
wk 3, whereas an interaction between diet and time 
effects (P < 0.001) was observed, characterized by an 
increase in the CON and CLA groups and a decrease 
in the HSO group over time points. The different pat-
terns over time resulted in lower milk yield in the HSO 
group compared with the CON (P = 0.004) and CLA 
(P = 0.003) groups at wk 15. The milk fat content 
was effectively depressed (P < 0.001) in the CLA and 
HSO groups at wk 3 and 15 relative to the CON group. 
Moreover, the HSO group showed even lower (P < 
0.001) milk fat content in comparison with the CLA 
group. Milk fat yield showed a similar pattern between 
groups at wk 3 (HSO < CLA < CON; P < 0.05). How-
ever, the differences in milk fat yield between the CON 
and CLA groups disappeared at wk 15. In contrast, the 
HSO group continued to have lower (P < 0.001) milk 
fat yield compared with the CON and CLA group at 
wk 15. The HSO group showed lower protein content 
compared with the other 2 groups and higher lactose 
content compared with the CLA group at wk 3 (P < 
0.05). These differences diminished in the following 
period and all the groups displayed similar protein and 
lactose contents at wk 15. However, the protein and 
lactose yields in the HSO group dropped considerably 
over time and were lower in the HSO group compared 
with the other 2 groups at wk 15 (P < 0.05). In addi-
tion, ECM was effectively depressed in the HSO group 
compared with the CON group at wk 3 and 15 (P < 
0.001). The SCC was not affected by the diets (data 
not shown).
Intake, Energy Balance, and BW Change
The HSO diet lowered DMI (P ≤ 0.008) of cows from 
wk 3 to 15 and ME intake (P < 0.001) from wk 7 to 
15 compared with the CON and CLA groups (Figure 
1). Cows in the CON group displayed marked BW loss 
from wk 3 to 7 (Figure 1). In contrast, the BW of the 
CLA and HSO groups slightly dropped from wk 3 to 
7, followed by increases from wk 7 to 15, resulting in 
higher BW compared with the CON group at wk 7 to 
15 (P = 0.02 for interaction of treatment and time). 
The EB of the CON group was lower (P = 0.03) than 
that of the HSO group and was numerically lower than 
that of the CLA group at wk 3 (Figure 1). However, 
in the CON group the EB increased rapidly after wk 
3, reaching a higher level (P = 0.03) than that in HSO 
group at wk 11. The interaction between EB calcula-
tion method and diet effect was not significant (P = 
0.31), suggesting the lack of influence of EB calculation 
method on the significance of the dietary effects.
Blood Metabolites, Hormones, and Biomarkers
Interactions between diet and time effects were ob-
served in blood concentrations of NEFA (P < 0.001) 
and BHB (P = 0.05; Table 3). At wk 3, we observed 
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lower blood NEFA (P < 0.001) and BHB (P = 0.001) 
concentrations in the CLA and HSO groups compared 
with the CON group. From wk 3 to 15, the NEFA 
concentration dropped considerably in the CON group 
(diet × time, P < 0.001), but kept stable in the CLA 
and HSO groups, eliminating the differences between 
groups at wk 15. Blood glucose, TG, and cholesterol 
concentrations increased (P < 0.001) over time in all 
3 groups. In addition, we observed higher (P < 0.001) 
blood glucose concentrations in the CLA and HSO 
groups compared with the CON group at both time 
points. Serum insulin concentration was not affected 
by the treatments. Blood concentration of hormones 
IGF-1 (P = 0.004), leptin (P = 0.031), and insulin (P < 
0.001) increased over time from wk 3 to 15. In addition, 
we observed higher (P = 0.01) leptin concentration in 
the HSO group compared with the CON group and 
higher somatotropin concentrations in the CLA (P < 
0.001) and HSO (P = 0.03) groups compared with the 
CON group at wk 3. An interaction (P = 0.04) between 
diet and time effects was observed on somatotropin 
concentration as it increased in the CON group, de-
creased in the CLA group, and kept stable in the HSO 
group, which eliminated the differences between groups 
at wk 15.
The concentrations of positive acute phase proteins, 
haptoglobin and ceruloplasmin, decreased over time (P 
< 0.001 and P = 0.01, respectively). The HSO group 
showed higher concentrations in comparison with the 
CON group in the whole period for both proteins (P = 
0.04 for haptoglobin and P < 0.001 for ceruloplasmin). 
The CLA group showed similar haptoglobin concentra-
tion in the whole period, whereas lower ceruloplasmin 
concentration (P < 0.001) at wk 3 compared with the 
CON group. Moreover, the CLA group had a lower (P 
< 0.001) concentration of ceruloplasmin at each time 
point compared with the HSO group. Bilirubin con-
centration showed a decrease (P < 0.001) over time 
in all groups and was lower in the CLA group at wk 
3 compared with CON (P = 0.003) and HSO (P < 
0.001). At wk 15, the difference between the CLA and 
CON groups disappeared and these 2 groups showed 
lower (P ≤ 0.01) levels compared with the HSO group.
Gene Expression in Adipose Tissue
Among genes involved in lipid metabolism, 6 genes 
displayed altered expression levels over time (Figure 
2 and Figure S1; https:// doi .org/ 10 .3168/ jds .2017 
-14298). We observed decreases or tendencies toward 
decrease in adipose triglyceride lipase (ATGL; P = 
0.02), diacylglycerol O-acyltransferase 1 (DGAT1; P 
= 0.09), hormone-sensitive lipase (LIPE; P = 0.06), 
perilipin 1 (PLIN1; P = 0.002), and sterol regulatory 
element binding transcription factor 1 (SREBF1; P 
= 0.02) over time. Diacylglycerol O-acyltransferase 2 
(DGAT2) was the only gene that tended to increase 
(P = 0.05) in expression from wk 3 to 15. Diet effects 
were only observed on the expression level of 1-acyl-
glycerol-3-phosphate O-acyltransferase 2 (AGPAT2; P 
= 0.004) and perilipin 2 (PLIN2; P = 0.005; Figure 
2). The expression of AGPAT2 was higher in the HSO 
group compared with the CLA group (P = 0.001) and 
CON group (P = 0.03) during the whole period. The 
Table 2. Milk yield and milk components of lactating cows fed different milk fat depression diets based on grass silage
Item  





CON CLA HSO Diet Time Diet × time
Milk yield (kg/d) 3 38.4 38.6 40.2 1.39 0.44 0.038 <0.001
 15 41.2a 43.3a 37.1b     
ECM (kg/d) 3 42.3a 39.1ab 35.1b 1.42 <0.001 0.45 0.20
 15 41.5a 40.3a 33.1b     
Fat yield (g/d) 3 1,840a 1,564b 1,224c 67.3 <0.001 0.052 0.45
 15 1,698a 1,535a 1,168b     
Protein yield (g/d) 3 1,365 1,379 1,322 48.0 0.13 0.98 0.17
 15 1,375ab 1,437a 1,252b     
Lactose yield (g/d) 3 1,734 1,735 1,851 62.1 0.75 0.031 <0.001
 15 1,882a 1,941a 1,703b     
Fat content (%) 3 4.79a 4.07b 3.06c 0.116 <0.001 <0.001 <0.001
 15 4.13a 3.56b 3.15c     
Protein content (%) 3 3.55a 3.58a 3.29b 0.052 0.16 <0.001 <0.001
 15 3.34 3.32 3.39     
Lactose content (%) 3 4.52ab 4.49a 4.61b 0.039 0.10 0.68 0.47
 15 4.57 4.48 4.59     
a–cDifferent superscripts indicate differences between the mean values in the same row (P < 0.05).
1CON = control diet; CLA = CLA-supplemented diet; HSO = high-starch diet supplemented with sunflower and fish oil (2:1).
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expression of PLIN2 was higher (P ≤ 0.004) in the 
CLA and HSO groups compared with the CON group 
during the whole period. The comparison within time 
points showed that the expression of adipocyte fatty 
acid binding protein 4 (FABP4) tended to be lower (P 
= 0.09) in the CLA group compared with the CON 
group at wk 3, whereas its expression was similar in all 
the groups at wk 15 (Figure 2). Mitochondrial glycerol-
3-phosphate acyltransferase (GPAM) expression tended 
to be higher (P = 0.08) in the HSO group compared 
with the CLA group at wk 15. Compared with the 
CON, the CLA and HSO diets tended to decrease (P ≤ 
0.07) the expression of LIPE at wk 3 but not at wk 15. 
In addition, the expression of peroxisome proliferator-
activated receptor gamma (PPARG) in the CON group 
was higher (P = 0.04) compared with the CLA group 
and tended to be higher (P = 0.09) compared with 
the HSO group at wk 3. From wk 3 to 15, PPARG 
expression decreased in the CON group whereas it 
increased in the CLA and HSO groups, characterized 
by the interaction (P = 0.020) between diet and time 
effects. As a consequence, the HSO tended (P = 0.07) 
to have higher PPARG expression compared with the 
CON group at wk 15.
The expression of most candidate genes associated 
with insulin signaling, inflammatory responses, and 
Figure 1. Body weight, energy balance, DMI, and ME intake of cows from wk 3 to 15 of lactation. The mean values in the graph are the LSM 
obtained from repeated measures ANOVA in SAS (release 9.3, SAS Institute Inc., Cary, NC). The error bars are the bootstrapped SE obtained 
from the same analysis. Different letters indicate the significant difference between groups at different time points. CON = control diet; CLA = 
CLA-supplemented diet; HSO = high-starch diet supplemented with sunflower and fish oil (2:1); T = time.
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sphingolipid metabolism displayed increases or tenden-
cies toward increase in their expression over time (Fig-
ure 3 and Supplemental Figure S1, https:// doi .org/ 10 
.3168/ jds .2017 -14298). These included protein kinase 
B1 (AKT1; P = 0.001), protein kinase B2 (AKT2; P < 
0.001), N-acylsphingosine amidohydrolase 1 (ASAH1; P 
= 0.098), caveolin 1 (CAV1; P < 0.001), insulin recep-
tor substrate 1 (IRS1; P < 0.001), nuclear factor κ B1 
(NFKB1; P = 0.056), sphingomyelin phosphodiesterase 
1 (SMPD1; P < 0.001), serine palmitoyltransferase long 
chain base subunit 1 (SPTLC1; P < 0.001), serine pal-
mitoyltransferase long chain base subunit 1 (SPTLC2; 
P < 0.001), serine palmitoyltransferase small subunit A 
(SPTSSA; P < 0.001), and toll-like receptor 4 (TLR4; 
P = 0.066). The CLA diet elevated the expression 
of AKT2 (P ≤ 0.002) and TLR4 (P ≤ 0.02) at wk 3 
relative to the CON and HSO diets (Figure 3). The 
expression of SPTLC1 tended to be raised (P ≤ 0.09) 
in the CLA group at wk 3 compared with the CON 
and HSO groups. In addition, the CLA group tended 
to have higher (P ≤ 0.09) expression of ASAH1, CAV1, 
and NFKB1 compared with the CON group at wk 3. In 
contrast to the CLA diet, the HSO diet mainly showed 
its effects at wk 15. The expression of AKT2 in the 
HSO group was higher (P = 0.047) compared with the 
CLA group and tended to be higher (P = 0.052) com-
pared with the CON group at wk 15. Similarly, SMPD1 
expression was elevated (P ≤ 0.01) by the HSO diet at 
wk 15 compared with the CON and CLA diets.
DISCUSSION
Milk Fat-Depressing Effect of Diets
Both the CLA and HSO diets effectively induced the 
depression of milk fat content at both wk 3 and 15. The 
HSO diet presented a stronger MFD effect compared 
with the CLA diet by inducing a more pronounced 
decrease in milk fat content and by significantly de-
creasing milk fat yield for longer period (until wk 15). 
Although not statistically significant, the drop of milk 
fat yield in the CLA group compared with the CON 
group at wk 15 was still numerically considerable (>150 
g/d). Furthermore, the depression of milk fat was also 
reflected by the profiles of ECM in the CLA and HSO 
groups at wk 3 and 15. Previously, CLA isomers have 
been proven to depress milk fat content by inhibiting 
the expression of various enzymes for fat synthesis in 
the mammary gland (Baumgard et al., 2000; Bauman 
et al., 2011). Decrease in milk fat content has also been 
observed in dairy cows fed high-starch diets, PUFA 
supplement, or both (Shingfield et al., 2006; Pirondini 
Table 3. Concentrations of blood metabolites of lactating cows fed different milk fat depression diets based on grass silage
Metabolite  





CON CLA HSO Diet Time Diet × time
NEFA2 (mmol/L) 3 0.59a 0.27b 0.25b 0.034 0.004 <0.001 <0.001
 15 0.16 0.22 0.26     
BHB (mmol/L) 3 1.39a 0.87b 0.86b 0.106 0.005 0.48 0.049
 15 1.20 1.14 0.92     
Glucose (mmol/L) 3 3.30b 3.74a 3.86a 0.112 <0.001 <0.001 0.73
 15 3.59b 4.09a 4.29a     
Triglycerides (mmol/L) 3 0.17b 0.24a 0.16b 0.020 0.12 <0.001 0.083
 15 0.26 0.26 0.23     
Cholesterol (mmol/L) 3 4.27 4.61 4.51 0.318 0.43 <0.001 0.30
 15 8.71 9.30 8.51     
Insulin (µIU/mL) 3 7.95 8.40 8.13 1.316 0.55 <0.001 0.60
 15 12.20 13.37 15.01     
IGF-1 (ng/mL) 3 5.11 4.83 5.07 0.517 0.87 0.004 0.82
 15 6.22 6.69 6.74     
Somatotropin (ng/mL) 3 3.30b 4.51a 3.98a 0.216 0.030 0.95 0.041
 15 3.86 3.98 3.98     
Leptin (ng/mL) 3 6.96b 7.23ab 7.65a 0.189 0.43 0.031 0.093
 15 7.67 7.71 7.52     
Haptoglobin (g/L) 3 0.08b 0.09ab 0.11a 0.009 0.11 <0.001 0.31
 15 0.04 0.04 0.05     
Ceruloplasmin (µmol/L) 3 3.30b 2.78c 3.78a 0.147 <0.001 0.012 0.036
 15 2.68b 2.67b 3.74a     
Bilirubin (µmol/L) 3 2.14a 1.49b 2.35a 0.137 0.001 <0.001 0.021
 15 1.16b 1.18b 1.71a     
a–cDifferent superscripts indicate differences between the mean values of feeding groups in the same row (P < 0.05). 
1CON = control group; CLA = group of cows in a CLA-supplemented diet; HSO = group of cows in a milk fat depression diet.
2NEFA = nonesterified fatty acids.
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Figure 2. Expression of genes involved in lipid metabolism in adipose tissue. The mean values in the graph are the LSM of log2-transformed 
data obtained from repeated measures ANOVA in SAS (release 9.3, SAS Institute Inc., Cary, NC). The error bars are the bootstrapped SE of 
log2-transformed data obtained from the same analysis. Difference between 2 feeding groups within time points: °P < 0.10; *P < 0.05; **P < 
0.01. CON = control diet; CLA = CLA-supplemented diet; HSO = high-starch diet supplemented with sunflower and fish oil (2:1); T = time; 
AGPAT2 = 1-acylglycerol-3-phosphate O-acyltransferase 2; FABP4 = adipocyte fatty acid binding protein 4; GPAM = mitochondrial glycerol-
3-phosphate acyltransferase; LIPE = hormone-sensitive lipase; PLIN2 = perilipin 2; PPARG = peroxisome proliferator-activated receptor 
gamma.
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Figure 3. Expression of genes involved in sphingolipid metabolism and insulin signaling. The mean values in the graph are the LSM of log2-
transformed data obtained from repeated measures ANOVA in SAS (release 9.3, SAS Institute Inc., Cary, NC). The error bars are the boot-
strapped SE of log2-transformed data obtained from the same analysis. Difference between 2 feeding groups within time points: °P < 0.10; *P < 
0.05; **P < 0.01; CON = control diet; CLA = CLA-supplemented diet; HSO = high-starch diet supplemented with sunflower and fish oil (2:1); 
T = time; AKT2 = protein kinase B2; ASAH1 = N-acylsphingosine amidohydrolase 1; NFKB1 = nuclear factor κ B1; SMPD1 = sphingomyelin 
phosphodiesterase 1; SPTLC1 = serine palmitoyltransferase long chain base subunit 1; TLR4 = toll-like receptor 4.
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et al., 2015). In addition, suppression of lipogenic genes 
in mammary gland was observed in cows fed plant and 
marine oil-derived long-chain PUFA (Ahnadi et al., 
2002; Angulo et al., 2012). Moreover, replacing barley 
with wheat slightly in the current study increased the 
starch content and was previously observed to decrease 
milk fat content in dairy goats (Bernard et al., 2016), 
in line with the performance of cows in the HSO group. 
The lack of significant difference in milk fat yield be-
tween the CLA and CON groups at wk 15 resulted 
from the numerically higher milk yield in the CLA 
group. The mechanisms underlying the effect of CLA 
on milk yield is unclear. Several publications reported 
that milk yield was not affected by either dietary CLA 
supplement or abomasal infusion of CLA (Baumgard 
et al., 2000; Perfield et al., 2002). On the other hand, 
increases in milk yield were observed in cows fed CLA-
supplemented diets (Shingfield et al., 2004; Galamb et 
al., 2017). Different from the CLA diet, the HSO diet 
decreased milk yield at wk 15, leading to decreased 
milk protein and lactose yields at wk 15 in the ab-
sence of differences in milk protein and lactose contents 
between groups. Correspondingly, reduced milk yield 
was observed in dairy goats fed high-starch diet versus 
low-starch diet (Bernard et al., 2016).
Alterations in Animal Performance and Blood 
Metabolites During MFD
Intakes of DM and ME were not influenced by the 
CLA diet, whereas they were remarkably decreased in 
the HSO group during lactation. Similar drops in DMI 
were observed when lactating cows were fed fish oil and 
sunflower oil (Shingfield et al., 2006; do Prado et al., 
2015). The decreases in DMI under dietary oil supple-
ments may have resulted from the negative effect of 
UFA on rumen function and the increase in flow of bio-
hydrogenation intermediates at duodenum (Shingfield 
et al., 2006). Based on previous studies, the decreased 
DMI may partly explain the decrease in milk yield 
and milk fat yield in the HSO group. All the groups 
developed NEB at wk 3 and increases in EB in the fol-
lowing period. Improved EB were previously reported 
in lactating dairy cows fed mixture of cis-9,trans-11 
and trans-10,cis-12 CLA at different stages of lactation 
(Odens et al., 2007; Schlegel et al., 2012). In contrast, 
contradictory results were reported on the EB of cows 
fed PUFA-rich oil due to the variation in DMI and 
milk production (Grummer and Carroll, 1991). In the 
present study, the numerically higher EB in the CLA 
group and the significantly higher EB in the HSO group 
compared with the CON group at wk 3 likely resulted 
from the reduction in milk fat synthesis. However, the 
decreased DMI in the HSO group may have slowed 
down the EB recovery to positive. In contrast, the EB 
of the CON group recovered to positive status at a 
faster rate compared with the other 2 groups from wk 
3 to 11. Collectively, the CLA and HSO diets alleviated 
the NEB at early lactation. However, the improvements 
in EB by the CLA and HSO diets diminished when EB 
reached a positive level at wk 7. The beneficial effects 
of the CLA and HSO diets on EB were also reflected 
by BW changes over time, as the CON group that had 
more serious NEB had also a greater BW loss over time 
compared with the CLA and HSO groups.
The adaptation to NEB during the periparturient pe-
riod in dairy cows includes the mobilization of body re-
serves to the tissues in demand (Ingvartsen, 2006). The 
NEFA derived from lipolysis in AT serves as an impor-
tant source for mammary fat synthesis and for energy 
production in the liver (Bauman and Griinari, 2003; 
Adewuyi et al., 2005). Incomplete hepatic oxidation of 
NEFA produces BHB (LeBlanc, 2010). Both plasma 
NEFA and BHB concentrations are used as indicators 
of lipid mobilization and EB in dairy cows (LeBlanc, 
2010). The lower blood NEFA and BHB concentrations 
in the CLA and HSO groups at wk 3 indicated less lipid 
mobilization and further supported the improved EB in 
these groups compared with the CON group at wk 3. 
The reduced lipid mobilization is likely associated with 
the depression of milk fat synthesis in the 2 groups. Our 
results are in line with previous studies in which plasma 
NEFA levels were decreased by dietary supplement of 
CLA isomers at early lactation (Odens et al., 2007; 
Hutchinson et al., 2011). Decreased NEFA and BHB 
concentrations were previously reported also in cows 
fed fish oil supplement in the first 2 wk of lactation 
(Ballou et al., 2009).
The MFD induced by the CLA and HSO diets were 
accompanied by increases in plasma glucose concen-
tration at wk 3 and 15. These results were consistent 
with previous results from cows fed CLA supplement in 
the first 7 wk of lactation (Odens et al., 2007; Hötger 
et al., 2013) and from those fed n-3 PUFA-rich fish 
oil and linseed (Ballou et al., 2009; Dirandeh et al., 
2016). Odens et al. (2007) attributed the increased 
glucose concentration to decreased whole-body in-
sulin sensitivity. Hötger et al. (2013) demonstrated 
that trans-10,cis-12 CLA reduced endogenous glucose 
production and at the same time reduced the glucose 
demand in the tissues, eventually leading to increased 
plasma glucose concentration. The increase in glucose 
concentrations in the CLA and HSO groups at wk 3 
may be driven by the higher somatotropin concentra-
tions in these 2 groups compared with the CON group, 
as somatotropin has been found to stimulate hepatic 
gluconeogenesis to supply the energy demand of the 
lactating mammary gland (Knapp et al., 1992). Plasma 
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somatotropin level generally increases with aggravated 
NEB at early lactation (Bell, 1995). However, the reason 
for the increase in somatotropin concentration in the 
present study is uncertain as the CLA and HSO groups 
actually showed improved EB compared with the CON 
group at wk 3. The blood leptin concentration in dairy 
cows generally decreases at early lactation, facilitating 
the allocation of glucose and NEFA toward the mam-
mary gland under NEB (Block et al., 2001). Therefore, 
higher plasma leptin concentration in the HSO group 
further supported the improved EB compared with the 
CON group. In addition, the increased plasma leptin 
concentration in the HSO group may explain the lower 
DM and ME intakes compared with the other 2 groups 
(Kokkonen et al., 2005).
The cows in all the groups showed an attenuation 
of the inflammatory condition moving away from par-
turition, as suggested by the reduction in the levels 
of inflammation indicators, haptoglobin, ceruloplas-
min, and bilirubin (Trevisi et al., 2012; Bertoni and 
Trevisi, 2013). Considering the diet effect, the CLA 
group showed a less severe systemic inflammatory con-
dition in comparison with the CON and HSO groups, 
particularly at wk 3, as supported by the lower levels of 
ceruloplasmin, and bilirubin in the plasma, which was 
consistent with a previous finding (Trevisi et al., 2008). 
The profiles of these biomarkers suggested that the 
CLA diet may attenuate NEB and decrease the meta-
bolic stress during the periparturient period (Trevisi et 
al., 2012). In contrast, the HSO group showed a slower 
decline in the inflammation status from wk 3 to 15, 
as suggested by the higher levels of ceruloplasmin and 
bilirubin compared with the other 2 groups.
Transcriptional Regulation of Lipid Metabolism  
in Adipose Tissue During MFD
The decrease or the tendency toward decrease in the 
expression of LIPE and ATGL in AT over time sug-
gested potential decreases in lipolysis from early to mid 
lactation in all of the groups, which may explain the 
declines in milk fat content at mid relative to early 
lactation. Expression of LIPE decreased in the CON 
and CLA groups, whereas it stayed stable in the HSO 
group, corresponding to the patterns of plasma NEFA 
level in these groups, which further indicated the role of 
LIPE in the lipolysis in AT during lactation. Therefore, 
the tendencies toward downregulation of LIPE expres-
sion in the CLA and HSO groups at wk 3 suggested the 
downregulation of lipolysis in AT at the transcription 
level compared with the CON group at early lactation. 
The potential downregulation of lipolysis was further 
supported by the lower expression of FABP4 in the 
CLA and HSO groups compared with the CON group, 
as FABP4 facilitates the transport of intracellular fatty 
acids toward cellular membrane through its interaction 
with LIPE (Furuhashi and Hotamisligil, 2008). Urrutia 
and Harvatine (2017) observed similar repression of 
lipolytic genes LIPE and FABP4 in AT when lactat-
ing dairy cows were treated with abomasal infusion of 
trans-10,cis-12 CLA. In addition, reduced lipolysis in 
AT was observed in periparturient goats fed PUFA-
rich oil (Invernizzi et al., 2016). Collectively with the 
profiles of NEFA, BHB, and EB, these alterations in 
gene expression may further support the decreased 
mobilization of body fat reserves in the CLA and HSO 
groups at early lactation in comparison with the CON 
group. Previously, a comparative experiment suggested 
that trans-10,cis-12 and cis-9,trans-11 CLA supplement 
decreased body fat mobilization by 40% from 1 to 42 
DIM (von Soosten et al., 2012). As a consequence of 
decreased fat mobilization, an increasing amount of fat 
may be deposited in subcutaneous AT as lipid droplets, 
deduced from the upregulation of PLIN2 in the CLA 
and HSO groups compared with the CON group, en-
coding a surface component of lipid droplets.
Shingfield et al. (2010) suggested that MFD leads 
to a shift of energy partitioning toward AT instead of 
lactating mammary gland. In an earlier study, MFD 
induced by abomasal infusion of trans-10,cis-12 CLA at 
mid lactation was accompanied by increased lipogenesis 
in AT in addition to decreased lipolysis, characterized 
by the upregulation of various lipogenic genes, includ-
ing fatty acid synthase (FASN), lipoprotein lipase 
(LPL), stearoyl-CoA desaturase (SCD), sterol regula-
tory element binding transcription factor 1 (SREBP1), 
thyroid hormone responsive (THRSP), and PPARG 
(Harvatine et al., 2009). We observed no upregulation 
of lipogenic genes but downregulation of PPARG in 
the CLA and HSO groups compared with the CON 
group at wk 3. At wk 15, higher expression of AGPAT2 
and GPAM suggested potentially greater TG synthe-
sis in the HSO group compared with the CON group. 
The upregulation of these genes in the HSO group was 
likely mediated by PPARG as the HSO group tended 
to have higher PPARG expression at the same time 
point. Furthermore, increased lipogenesis in the HSO 
group compared with the CON group at wk 15 may 
have resulted in increased deposition of lipid droplets 
as suggested by the higher expression of PLIN2. Corre-
sponding results were previously observed in dairy cows 
fed PUFA-rich oil, as the upregulation of various lipo-
genic genes in AT, including PLIN2, lipin 1 (LPIN1), 
SCD, LPL, THRSP, and PPARG (Thering et al., 2009; 
Schmitt et al., 2011). In contrast, we observed little or 
no effect of the CLA diet on the gene expression related 
to lipogenesis in AT at wk 15, different from the results 
reported by Harvatine et al. (2009). The discrepancy 
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may have resulted from the differences in CLA isomer 
type (mixture of cis-9,trans-11 and trans-10,cis-12 CLA 
in diet vs. pure trans-10,cis-12 CLA through abomasal 
infusion) and doses (10.0–15.0 g/d for each isomer vs. 
7.5 g/d trans-10,cis-12 CLA) between the present study 
and Harvatine et al. (2009), respectively.
Collectively, both the CLA and HSO treatments 
downregulated lipolysis in AT at gene expression level 
at early lactation when cows were in NEB, whereas the 
effects disappeared in mid lactation when EB returned 
to positive. In contrast, a potential upregulation of li-
pogenesis was observed only in the HSO group but not 
in the CLA group and only in mid versus early lacta-
tion. Therefore, the response of AT to MFD may be 
dependent on the energy status of the cows, the stage 
of lactation, or the composition of the diet causing 
MFD. These alterations of the lipid metabolism in AT 
reflected the shift of energy partitioning toward AT and 
might have increased body fat reserves during MFD.
Insulin Signaling and Ceramide Metabolism  
During MFD
Regardless of diet, the transcription of most candi-
date genes involved in insulin signaling, inflammatory 
response, and ceramide metabolism considerably in-
creased over time, which can be considered as a part of 
the physiological adaptation to the transition from NEB 
to positive EB. Overall, the CLA diet induced smaller 
variation in the expression of insulin-related genes from 
wk 3 to 15 compared with the other 2 groups. We sug-
gest that the metabolic challenges at early lactation 
may be attenuated by the CLA diet and this may lead 
to a milder physiological adaptation to the transition 
compared with the other 2 diets.
The CLA diet tended to alter the local inflammatory 
responses in AT by upregulating TLR4 and NFKB1 
expression. It can be interpreted that the activation 
of TLR4 and its downstream gene NFKB1 potentially 
upregulated the inflammatory signaling that stimu-
lated the production of proinflammatory cytokines (Shi 
et al., 2006; Kawai and Akira, 2007), which is in line 
with the findings in human and mouse, suggesting that 
the anti-adipogenic effect of trans-10,cis-12 CLA was 
associated with the upregulation of NFKB-induced in-
flammatory response (Chung et al., 2005; Hommelberg 
et al., 2010). The transcriptional upregulation of AT in-
flammation seemed to be contradictory to the change in 
systemic inflammation under CLA treatment. However, 
the influence of the CLA diet on systemic inflamma-
tion may have been derived from its effects on hepatic 
metabolism because the acute phase proteins used as 
inflammation indicators are mainly synthesized in the 
liver (Bertoni and Trevisi, 2013; Tothova et al., 2014), 
which may explain the different responses of between 
systemic inflammation and AT inflammation to the 
CLA diet. An alternative interpretation of TLR4 and 
NFKB1 upregulation is that it indicated the resistance 
of AT to inflammatory stimuli as suggested by Chen 
et al. (2012) and Minuti et al. (2015), which was in 
line with our observation in systemic inflammation. In 
addition, the CLA diet may affect the PI3K insulin 
signaling pathway by altering the expression of AKT2. 
Pettersson et al. (2013) suggested the importance of 
AKT2 on insulin signaling as the mRNA abundance of 
AKT2 was inversely correlated with the index indicat-
ing IR. However, it cannot be exclusively concluded 
that IR was reduced in the CLA group only based on 
the upregulation of AKT2 because the expression of its 
upstream gene IRS1 in PI3K pathway was not affected 
by the CLA diet.
The cis-9,trans-11 and trans-10,cis-12 CLA were re-
ported to have different influences on IR in human and 
mouse adipocytes. Feeding cis-9,trans-11 CLA to mice 
was found to improve whole-body insulin sensitivity, 
increase the level of insulin-signaling pathway proteins, 
and decrease the transcription of pro-inflammatory cy-
tokines in white AT, including interleukin-6 and tumor 
necrosis factor α (Moloney et al., 2007). In contrast, 
trans-10,cis-12 CLA was reported to increase IR in hu-
man and mouse adipocytes by promoting the inflam-
matory responses (House et al., 2005). In the present 
study, we suggest that the CLA diet likely attenuated 
IR in AT of dairy cows based on the profiles of EB, BW, 
NEFA, BHB, and the transcription of genes involved 
in lipid metabolism. However, the current results are 
insufficient to indicate the dominant CLA isomer that 
influenced AT metabolism as the effect of different iso-
mers in ruminants may be different from that known 
in monogastrics. In addition, the differences in energy 
status and CLA doses pose further difficulties in the 
comparison between studies on ruminants and those 
on human and rodents. In addition, the upregulation 
of proinflammatory genes in AT seemed to be contra-
dictory to the attenuated IR we expected. However, 
Hommelberg et al. (2010) reported that trans-10,cis-12 
CLA increased NFκB activation 13-fold without in-
ducing IR in cultured murine skeletal muscle cells. 
Moreover, the IR in AT may be also associated with 
systemic inflammation, which was reduced by the CLA 
supplement.
The CLA diet may influence IR through the regula-
tion of ceramide metabolism at gene expression level. 
The SPTLC1 and SPTLC2 encode the long-chain sub-
units of serine palmitoyltransferase, the rate-limiting 
enzyme involved in ceramide de novo synthesis (Hor-
nemann et al., 2009; Gault et al., 2010). The higher 
SPTLC1 expression in the CLA group at wk 3 may 
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indicate potentially greater ceramide synthesis com-
pared with the other 2 groups. However, the hydrolysis 
of ceramide may be promoted by the CLA diet at the 
same time, deduced from the upregulation of ASAH1, 
a gene encoding acid ceramidase (Gault et al., 2010). 
These changes jointly suggested that the CLA group 
may have more active ceramide metabolism compared 
with the CON and HSO groups. Previously, Wang and 
Fromm (2015) observed in 3T3-L1 adipocytes that 
trans-10,cis-12 CLA treatment largely elevated the lev-
els of sphinganine and sphingosine, an intermediate in 
ceramide de novo synthesis and a product of ceramide 
hydrolysis, respectively, which corresponds to the up-
regulation of SPTLC1 and ASAH1 expression in our 
CLA group. In addition, they observed increased ce-
ramide level in the cell culture treated by trans-10,cis-12 
CLA and claimed the lipid-lowering effect of CLA to be 
ceramide-dependent. Similar elevation of ceramide level 
in the skeletal muscle and increased IR was reported 
in overweight and nondiabetic humans who received 
dietary supplement of cis-9,trans-11 and trans-10,cis-12 
CLA (Thrush et al., 2007). However, the current results 
were insufficient to unambiguously conclude that ce-
ramide homeostasis changed as no measurements were 
conducted on ceramide concentration.
Collectively, the CLA diet potentially promoted the 
inflammatory responses in AT and influenced the insu-
lin signaling and ceramide metabolism pathways in AT 
of dairy cows at gene expression level mainly at early 
lactation. However, it cannot be concluded that the 
CLA diet suppressed the lipid mobilization from AT 
through the regulation of IR because a contradiction 
exists between the indications of IR based on the physi-
ological measurements and the gene expression profiles 
associated with inflammation in AT. Alternatively, 
CLA may influence the lipid metabolism by directly 
suppressing PPARγ activity through the inhibition of 
endogenous ligand formation (Brown et al., 2003). In 
contrast to the CLA diet, the HSO diet had no influence 
on the transcription of insulin-related candidate genes 
at early lactation. At wk 15, the HSO group displayed 
potentially more active insulin signaling and greater 
ceramide production through sphingomyelin hydrolysis 
compared with the other 2 groups, as suggested by the 
higher expression of AKT2 and SMPD1. However, the 
present study provided insufficient evidence to assess 
the effects of HSO diet on IR. Overall, the CLA and 
HSO diets induced different effects in the regulation 
of IR-associated pathways, although they resulted in 
similar effects in suppressing the lipid mobilization 
from AT. The difference between the diets may have 
partly resulted from their different energy contents. 
Moreover, dietary PUFA supplement is believed to 
induce MFD by modifying ruminal biohydrogenation 
of fatty acids. Shingfield et al. (2006) provided cows 
a similar oil supplement as in the present study and 
observed the changes in the concentration of various 
fatty acids in milk, including 4:0 to 18:0 (even number 
of carbon atoms), cis 18:1, trans 18:1, trans 18:2, trans-
9,trans-11 CLA, 20:5n-3, and 22:6n-3, in addition to 
the elevation of trans-10,cis-12 and cis-9,trans-11 CLA. 
On the other hand, increases in various trans-10 con-
taining intermediates but no change in cis-9,trans-11 
and trans-10,cis-12 CLA in the digesta flow at the 
omasum were observed in cows fed a high-concentrate 
diet supplemented with sunflower oil (Ventto et al., 
2017). Therefore, the MFD induced by dietary PUFA 
may result from the comprehensive effects of various 
modified biohydrogenation intermediates rather than 
simply from that of specific CLA isomers.
CONCLUSIONS
The diet containing a mixture of trans-10,cis-12 CLA 
and cis-9,trans-11 CLA and the high-starch diet supple-
mented with a mixture of sunflower oil and fish oil (2:1) 
effectively depressed milk fat yield and content at early 
(wk 3) and mid lactation (wk 15) in the absence of 
significant changes in milk protein and lactose contents. 
In addition, the HSO diet considerably lowered DM 
and ME intakes from wk 3 to 15. The decreased energy 
intake may result in the decrease in milk yield and milk 
fat yield in the HSO group from wk 3 to 15. As a 
consequence of decreased nutrient requirement for milk 
synthesis, both the CLA and HSO diets potentially 
decreased the mobilization of body fat from subcuta-
neous AT as deduced from the reduced transcription 
of lipolytic genes in AT at early lactation when dairy 
cows were in NEB, and supported by the lower blood 
NEFA and BHB levels in these groups compared with 
the control at the same time point. The suppression on 
lipolysis in AT by these 2 diets diminished at mid lacta-
tion when EB returned to positive. The CLA and HSO 
diets displayed no effect on the lipogenesis in AT at 
early lactation. However, increased lipogenesis at gene 
expression level was observed in AT of the HSO group 
at mid lactation. Collectively, the CLA and HSO diets 
induced a shift in energy partitioning from mammary 
gland toward AT. The effects were particularly obvious 
during the severe NEB at early lactation. The CLA and 
HSO diets may regulate the lipid metabolism in AT 
through different mechanisms because the CLA diet af-
fected the expression of genes involved in insulin signal-
ing pathways, inflammatory responses, and ceramide 
metabolism, whereas little change in these pathways 
was observed in cows receiving the HSO diet.
7968 QIN ET AL.
Journal of Dairy Science Vol. 101 No. 9, 2018
ACKNOWLEDGMENTS
The experiment was designed by the late Kevin 
Shingfield, and his scientific expertise and inspiration 
were of utmost importance throughout the study. The 
financial support, and provision of CLA supplement 
and fish oil by BASF, Ludwigshafen, Germany, is ap-
preciated. The gene expression analyses were funded by 
Niemi-säätiö, Finland, and Future Fund of the Univer-
sity of Helsinki. NQ was financially supported by the 
AGFOREE Doctoral Programme in Sustainable Use 
of Renewable Natural Resources at the University of 
Helsinki.
REFERENCES
Adewuyi, A. A., E. Gruys, and F. J. C. M. van Eerdenburg. 2005. 
Non esterified fatty acids (NEFA) in dairy cattle. A review. Vet. 
Q. 27:117–126.
Ahnadi, C. E., N. Beswick, L. Delbecchi, J. J. Kennelly, and P. Lac-
asse. 2002. Addition of fish oil to diets for dairy cows. II. Effects 
on milk fat and gene expression of mammary lipogenic enzymes. J. 
Dairy Res. 69:521–531.
Andersen, C., J. Jensen, and T. Orntoft. 2004. Normalization of real-
time quantitative reverse transcription-PCR data: A model-based 
variance estimation approach to identify genes suited for normal-
ization, applied to bladder and colon cancer data sets. Cancer Res. 
64:5245–5250.
Angulo, J., L. Mahecha, K. Nuernberg, G. Nuernberg, D. Dannen-
berger, M. Olivera, M. Boutinaud, C. Leroux, E. Albrecht, and L. 
Bernard. 2012. Effects of polyunsaturated fatty acids from plant 
oils and algae on milk fat yield and composition are associated 
with mammary lipogenic and SREBF1 gene expression. Animal 
6:1961–1972.
Ballou, M. A., R. C. Gomes, S. O. Juchem, and E. J. DePeters. 2009. 
Effects of dietary supplemental fish oil during the peripartum pe-
riod on blood metabolites and hepatic fatty acid compositions and 
total triacylglycerol concentrations of multiparous Holstein cows. 
J. Dairy Sci. 92:657–669.
Bauman, D. E., and J. M. Griinari. 2003. Nutritional regulation of 
milk fat synthesis. Annu. Rev. Nutr. 23:203–227.
Bauman, D. E., K. J. Harvatine, and A. L. Lock. 2011. Nutrigenomics, 
rumen-derived bioactive fatty acids, and the regulation of milk fat 
synthesis. Annu. Rev. Nutr. 31:299–319.
Baumgard, L., B. Corl, D. Dwyer, A. Saebo, and D. Bauman. 2000. 
Identification of the conjugated linoleic acid isomer that inhibits 
milk fat synthesis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 
278:R179–R184.
Bell, A. 1995. Regulation of organic nutrient metabolism during 
transition from late pregnancy to early lactation. J. Anim. Sci. 
73:2804–2819.
Bernard, L., P. Toral, J. Rouel, and Y. Chilliard. 2016. Effects of ex-
truded linseed and level and type of starchy concentrate in a diet 
containing fish oil on dairy goat performance and milk fatty acid 
composition. Anim. Feed Sci. Technol. 222:31–42.
Bertoni, G., and E. Trevisi. 2013. Use of the liver activity index and 
other metabolic variables in the assessment of metabolic health in 
dairy herds. Vet. Clin. North Am. Food Anim. Pract. 29:413–431.
Block, S., W. Butler, R. Ehrhardt, A. Bell, M. Van Amburgh, and 
Y. Boisclair. 2001. Decreased concentration of plasma leptin in 
periparturient dairy cows is caused by negative energy balance. J. 
Endocrinol. 171:339–348.
Brown, J. M., M. S. Boysen, S. S. Jensen, R. F. Morrison, J. Storkson, 
R. Lea-Currie, M. Pariza, S. Mandrup, and M. K. McIntosh. 2003. 
Isomer-specific regulation of metabolism and PPARgamma signal-
ing by CLA in human preadipocytes. J. Lipid Res. 44:1287–1300.
Calamari, L., A. Ferrari, A. Minuti, and E. Trevisi. 2016. Assessment 
of the main plasma parameters included in a metabolic profile of 
dairy cow based on Fourier transform mid-infrared spectroscopy: 
Preliminary results. BMC Vet. Res. 12:4.
Chavez, J. A., T. A. Knotts, L. Wang, G. Li, R. T. Dobrowsky, G. L. 
Florant, and S. A. Summers. 2003. A role for ceramide, but not 
diacylglycerol, in the antagonism of insulin signal transduction by 
saturated fatty acids. J. Biol. Chem. 278:10297–10303.
Chavez, J. A., and S. A. Summers. 2012. A ceramide-centric view of 
insulin resistance. Cell Metab. 15:585–594.
Chen, Y., M. Oba, and L. L. Guan. 2012. Variation of bacterial com-
munities and expression of toll-like receptor genes in the rumen of 
steers differing in susceptibility to subacute ruminal acidosis. Vet. 
Microbiol. 159:451–459.
Chung, S. K., J. M. Brown, J. N. Provo, R. Hopkins, and M. K. Mc-
Intosh. 2005. Conjugated linoleic acid promotes human adipocyte 
insulin resistance through NF kappa B-dependent cytokine pro-
duction. J. Biol. Chem. 280:38445–38456.
Dirandeh, E., A. Towhidi, Z. Ansari, S. Zeinoaldini, and M. Gan-
jkhanlou. 2016. Effects of dietary supplementation with different 
polyunsaturated fatty acids on expression of genes related to so-
matotropic axis function in the liver, selected blood indicators, 
milk yield and milk fatty acids profile in dairy cows. Ann. Anim. 
Sci. 16:1045–1058.
do Prado, R. M., C. Cortes, C. Benchaar, and H. V. Petit. 2015. In-
teraction of sunflower oil with monensin on milk composition, milk 
fatty acid profile, digestion, and ruminal fermentation in dairy 
cows. Anim. Feed Sci. Technol. 207:85–92.
Drackley, J., H. Dann, G. Douglas, N. Guretzky, N. Litherland, J. 
Underwood, and J. Loor. 2005. Physiological and pathological ad-
aptations in dairy cows that may increase susceptibility to peripar-
turient diseases and disorders. Ital. J. Anim. Sci. 4:323–344.
European Council. 1986. Council Directive of 24 November 1986 on 
the approximation of laws, regulations and administrative provi-
sions of the Member States regarding the protection of animals 
used for experimental and other scientific purposes (86/609/EEC). 
Off. J. Eur. Comm. L358: 1–28.
Furuhashi, M., and G. S. Hotamisligil. 2008. Fatty acid-binding pro-
teins: Role in metabolic diseases and potential as drug targets. 
Nat. Rev. Drug Discov. 7:489–503.
Galamb, E., V. Faigl, M. Keresztes, Z. Csillik, A. Troescher, P. Elek, 
M. Kulcsar, G. Huszenicza, H. Febel, and F. Husveth. 2017. Effect 
of pre- and post-partum supplementation with lipid-encapsulated 
conjugated linoleic acid on milk yield and metabolic status in mul-
tiparous high-producing dairy cows. J. Anim. Physiol. Anim. Nutr. 
(Berl.) 101:1026–1035.
Gault, C. R., L. M. Obeid, and Y. A. Hannun. 2010. An overview of 
sphingolipid metabolism: From synthesis to breakdown. Adv. Exp. 
Med. Biol. 688:1–23.
Gervais, R., J. W. McFadden, A. J. Lengi, B. A. Corl, and P. Y. Ch-
ouinard. 2009. Effects of intravenous infusion of trans-10, cis-12 
18: 2 on mammary lipid metabolism in lactating dairy cows. J. 
Dairy Sci. 92:5167–5177.
Grummer, R., and D. Carroll. 1991. Effects of dietary-fat on metabolic 
disorders and reproductive-performance of dairy-cattle. J. Anim. 
Sci. 69:3838–3852.
Harvatine, K. J., and D. E. Bauman. 2006. SREBP1 and thyroid hor-
mone responsive spot 14 (S14) are involved in the regulation of 
bovine mammary lipid synthesis during diet-induced milk fat de-
pression and treatment with CLA. J. Nutr. 136:2468–2474.
Harvatine, K. J., J. W. I. I. Perfield, and D. E. Bauman. 2009. Expres-
sion of enzymes and key regulators of lipid synthesis is upregulated 
in adipose tissue during CLA-induced milk fat depression in dairy 
cows. J. Nutr. 139:849–854.
Hötger, K., H. M. Hammon, C. Weber, S. Goers, A. Troescher, R. M. 
Bruckmaier, and C. C. Metges. 2013. Supplementation of conju-
gated linoleic acid in dairy cows reduces endogenous glucose pro-
duction during early lactation. J. Dairy Sci. 96:2258–2270.
Hommelberg, P. P. H., R. C. J. Langen, A. M. W. J. Schols, A. L. 
M. Van Essen, F. J. M. Snepvangers, R. P. Mensink, and J. Plat. 
2010. Trans fatty acid-induced NF-κB activation does not induce 
Journal of Dairy Science Vol. 101 No. 9, 2018
SUPPRESSION OF LIPID MOBILIZATION 7969
insulin resistance in cultured murine skeletal muscle cells. Lipids 
45:285–290.
Hornemann, T., A. Penno, M. F. Ruetti, D. Ernst, F. Kivrak-Pfiffner, 
L. Rohrer, and A. von Eckardstein. 2009. The SPTLC3 subunit of 
serine palmitoyltransferase generates short chain sphingoid bases. 
J. Biol. Chem. 284:26322–26330.
House, R. L., J. P. Cassady, E. J. Eisen, M. K. McIntosh, and J. Odle. 
2005. Conjugated linoleic acid evokes de-lipidation through the 
regulation of genes controlling lipid metabolism in adipose and 
liver tissue. Obes. Rev. 6:247–258.
Hutchinson, I., M. J. de Veth, C. Stanton, R. J. Dewhurst, P. Lo-
nergan, A. C. O. Evans, and S. T. Butler. 2011. Effects of lipid-
encapsulated conjugated linoleic acid supplementation on milk 
production, bioenergetic status and indicators of reproductive per-
formance in lactating dairy cows. J. Dairy Res. 78:308–317.
Ingvartsen, K. L. 2006. Feeding- and management-related diseases in 
the transition cow–Physiological adaptations around calving and 
strategies to reduce feeding-related diseases. Anim. Feed Sci. Tech-
nol. 126:175–213.
Invernizzi, G., S. Modina, D. Corbani, V. Bronzo, L. F. Pisani, J. M. 
Caputo, A. Agazzi, V. Dell’Orto, and G. Savoini. 2016. Hepatic 
and subcutaneous adipose tissue variations in transition dairy 
goats fed saturated or unsaturated fat supplemented diets. Small 
Rumin. Res. 144:211–219.
Kalscheur, K. F., B. B. Teter, L. S. Piperova, and R. A. Erdman. 
1997. Effect of dietary forage concentration and buffer addition on 
duodenal flow of trans-C-18:1 fatty acids and milk fat production 
in dairy cows. J. Dairy Sci. 80:2104–2114.
Kawai, T., and S. Akira. 2007. Signaling to NF-κB by toll-like recep-
tors. Trends Mol. Med. 13:460–469.
Kennedy, A., A. Overman, K. LaPoint, R. Hopkins, T. West, C. 
Chuang, K. Martinez, D. Bell, and M. McIntosh. 2009. Conju-
gated linoleic acid-mediated inflammation and insulin resistance 
in human adipocytes are attenuated by resveratrol. J. Lipid Res. 
50:225–232.
Knapp, J. R., H. C. Freetly, B. L. Reis, C. C. Calvert, and R. L. 
Baldwin. 1992. Effects of somatotropin and substrates on pat-
terns of liver metabolism in lactating dairy cattle. J. Dairy Sci. 
75:1025–1035.
Kokkonen, T., J. Taponen, T. Anttila, L. Syrjala-Qvist, C. Delavaud, 
Y. Chilliard, M. Tuori, and A. Tesfa. 2005. Effect of body fatness 
and glucogenic supplement on lipid and protein mobilization and 
plasma leptin in dairy cows. J. Dairy Sci. 88:1127–1141.
LeBlanc, S. 2010. Monitoring metabolic health of dairy cattle in the 
transition period. J. Reprod. Dev. 56:S29–S35.
Minuti, A., A. Palladino, M. J. Khan, S. Alqarni, A. Agrawal, F. 
Piccioli-Capelli, F. Hidalgo, F. C. Cardoso, E. Trevisi, and J. J. 
Loor. 2015. Abundance of ruminal bacteria, epithelial gene expres-
sion, and systemic biomarkers of metabolism and inflammation 
are altered during the peripartal period in dairy cows. J. Dairy 
Sci. 98:8940–8951.
Moloney, F., S. Toomey, E. Noone, A. Nugent, B. Allan, C. E. Loscher, 
and H. M. Roche. 2007. Antidiabetic effects of cis-9, trans-11-con-
jugated linoleic acid may be mediated via anti-inflammatory ef-
fects in white adipose tissue. Diabetes 56:574–582.
Moore, C., H. Hafliger, O. Mendivil, S. Sanders, D. Bauman, and L. 
Baumgard. 2004. Increasing amounts of conjugated linoleic acid 
(CLA) progressively reduces milk fat synthesis immediately post-
partum. J. Dairy Sci. 87:1886–1895.
Natural Resources Institute Finland. 2015. Energy Requirements 
for Dairy Cows. Accessed Jun. 13, 2015. http:// www .luke .fi/ 
rehutaulukot.
Odens, L. J., R. Burgos, M. Innocenti, M. J. VanBaale, and L. H. 
Baumgard. 2007. Effects of varying doses of supplemental conju-
gated linoleic acid on production and energetic variables during 
the transition period. J. Dairy Sci. 90:293–305.
Perfield, J., G. Bernal-Santos, T. Overton, and D. Bauman. 2002. Ef-
fects of dietary supplementation of rumen-protected conjugated 
linoleic acid in dairy cows during established lactation. J. Dairy 
Sci. 85:2609–2617.
Pettersson, A. M. L., B. M. Stenson, S. Lorente-Cebrian, D. P. An-
dersson, N. Mejhert, J. Kratzel, G. Astrom, I. Dahlman, A. V. 
Chibalin, P. Arner, and J. Laurencikiene. 2013. LXR is a nega-
tive regulator of glucose uptake in human adipocytes. Diabetologia 
56:2044–2054.
Piccioli-Cappelli, F., J. J. Loor, C. J. Seal, A. Minuti, and E. Trevisi. 
2014. Effect of dietary starch level and high rumen-undegradable 
protein on endocrine-metabolic status, milk yield, and milk com-
position in dairy cows during early and late lactation. J. Dairy Sci. 
97:7788–7803.
Pirondini, M., S. Colombini, M. Mele, L. Malagutti, L. Rapetti, G. 
Galassi, and G. M. Crovetto. 2015. Effect of dietary starch concen-
tration and fish oil supplementation on milk yield and composi-
tion, diet digestibility, and methane emissions in lactating dairy 
cows. J. Dairy Sci. 98:357–372.
Pupovac, V., and M. Petrovecki. 2011. Summarizing and presenting 
numerical data. Biochem. Med. (Zagreb) 21:106–110.
Qin, N., T. Kokkonen, S. Salin, T. Seppanen-Laakso, J. Taponen, 
A. Vanhatalo, and K. Elo. 2017. Prepartal overfeeding alters the 
lipidomic profiles in the liver and the adipose tissue of transition 
dairy cows. Metabolomics 13:21.
Rico, J. E., V. V. R. Bandaru, J. M. Dorskind, N. J. Haughey, and J. 
W. McFadden. 2015. Plasma ceramides are elevated in overweight 
Holstein dairy cows experiencing greater lipolysis and insulin resis-
tance during the transition from late pregnancy to early lactation. 
J. Dairy Sci. 98:7757–7770.
Rico, J. E., S. S. Samii, A. T. Mathews, J. Lovett, N. J. Haughey, and 
J. W. McFadden. 2017. Temporal changes in sphingolipids and 
systemic insulin sensitivity during the transition from gestation to 
lactation. PLoS One 12:e0176787.
Rozen, S., and H. Skaletsky. 2000. Primer3 on the WWW for Gen-
eral Users and for Biologist Programmers. Pages 365–386 in Bio-
informatics Methods and Protocols. Methods in Molecular Biol-
ogy™. Vol. 132. S. Misener and S. A. Krawetz, ed. Humana Press, 
Totowa, NJ.
Ruijter, J. M., C. Ramakers, W. M. Hoogaars, Y. Karlen, O. Bakker, 
M. J. van den Hoff, and A. F. Moorman. 2009. Amplification ef-
ficiency: Linking baseline and bias in the analysis of quantitative 
PCR data. Nucleic Acids Res. 37:e45.
Salin, S., J. Taponen, K. Elo, I. Simpura, A. Vanhatalo, R. Boston, 
and T. Kokkonen. 2012. Effects of abomasal infusion of tallow or 
camelina oil on responses to glucose and insulin in dairy cows dur-
ing late pregnancy. J. Dairy Sci. 95:3812–3825.
Saremi, B., S. Winand, P. Friedrichs, A. Kinoshita, J. Rehage, S. Dae-
nicke, S. Haeussler, G. Breves, M. Mielenz, and H. Sauerwein. 
2014. Longitudinal profiling of the tissue-specific expression of 
genes related with insulin sensitivity in dairy cows during lactation 
focusing on different fat depots. PLoS One 9:e86211.
Schlegel, G., R. Ringseis, W. Windisch, F. J. Schwarz, and K. Eder. 
2012. Effects of a rumen-protected mixture of conjugated linoleic 
acids on hepatic expression of genes involved in lipid metabolism 
in dairy cows. J. Dairy Sci. 95:3905–3918.
Schmitt, E., M. A. Ballou, M. N. Correa, E. J. DePeters, J. K. Drack-
ley, and J. J. Loor. 2011. Dietary lipid during the transition period 
to manipulate subcutaneous adipose tissue peroxisome prolifera-
tor-activated receptor-gamma co-regulator and target gene expres-
sion. J. Dairy Sci. 94:5913–5925.
Selim, S., T. Kokkonen, J. Taponen, A. Vanhatalo, and K. Elo. 2015. 
Effect of prepartal ad libitum feeding of grass silage on transcrip-
tional adaptations of the liver and subcutaneous adipose tissue in 
dairy cows during the periparturient period. J. Dairy Sci. 98:5515–
5528.
Selim, S., S. Salin, J. Taponen, A. Vanhatalo, T. Kokkonen, and K. T. 
Elo. 2014. Prepartal dietary energy alters transcriptional adapta-
tions of the liver and subcutaneous adipose tissue of dairy cows 
during the transition period. Physiol. Genomics 46:328–337.
Shi, H., M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier. 
2006. TLR4 links innate immunity and fatty acid-induced insulin 
resistance. J. Clin. Invest. 116:3015–3025.
7970 QIN ET AL.
Journal of Dairy Science Vol. 101 No. 9, 2018
Shingfield, K. J., D. E. Beever, C. K. Reynolds, S. K. Gulati, D. J. 
Humphries, B. Lupoli, G. Hervas, and M. J. Griinari. 2004. Ef-
fect of rumen protected conjugated linoleic acid on energy me-
tabolism of dairy cows during early to mid-lactation. J. Anim. Sci. 
82:307–307.
Shingfield, K. J., L. Bernard, C. Leroux, and Y. Chilliard. 2010. Role 
of trans fatty acids in the nutritional regulation of mammary lipo-
genesis in ruminants. Animal 4:1140–1166.
Shingfield, K. J., S. Jaakkola, and P. Huhtanen. 2002. Effect of forage 
conservation method, concentrate level and propylene glycol on 
diet digestibility, rumen fermentation, blood metabolite concen-
trations and nutrient utilisation of dairy cows. Anim. Feed Sci. 
Technol. 97:1–21.
Shingfield, K. J., C. Reynolds, G. Hervas, J. Griinari, A. Grandison, 
and D. Beever. 2006. Examination of the persistency of milk fatty 
acid composition responses to fish oil and sunflower oil in the diet 
of dairy cows. J. Dairy Sci. 89:714–732.
Thering, B. J., D. E. Graugnard, P. Piantoni, and J. J. Loor. 2009. 
Adipose tissue lipogenic gene networks due to lipid feeding and 
milk fat depression in lactating cows. J. Dairy Sci. 92:4290–4300.
Thrush, A. B., A. Chabowski, G. J. Heigenhauser, B. W. McBride, 
M. Or-Rashid, and D. J. Dyck. 2007. Conjugated linoleic acid in-
creases skeletal muscle ceramide content and decreases insulin sen-
sitivity in overweight, non-diabetic humans. Appl. Physiol. Nutr. 
Metab. 32:372–382.
Tothova, C., O. Nagy, and G. Kovac. 2014. Acute phase proteins and 
their use in the diagnosis of diseases in ruminants: A review. Vet. 
Med. 59:163–180.
Trevisi, E., M. Amadori, S. Cogrossi, E. Razzuoli, and G. Bertoni. 
2012. Metabolic stress and inflammatory response in high-yielding, 
periparturient dairy cows. Res. Vet. Sci. 93:695–704.
Trevisi, E., A. Ferrari, F. Piccioli-Cappelli, and G. Bertoni. 2008. 
Energy balance indexes and blood changes of dairy cows supple-
mented with rumen protected CLA in late pregnancy and early 
lactation. J. Dairy Sci. 91(E-Suppl. 1):77. (Abstr.)
Urrutia, N., and K. J. Harvatine. 2017. Effect of conjugated linoleic 
acid and acetate on milk fat synthesis and adipose lipogenesis in 
lactating dairy cows. J. Dairy Sci. 100:5792–5804.
Vahmani, P., K. E. Glover, and A. H. Fredeen. 2014. Effects of pasture 
versus confinement and marine oil supplementation on the expres-
sion of genes involved in lipid metabolism in mammary, liver, and 
adipose tissues of lactating dairy cows. J. Dairy Sci. 97:4174–4183.
Vailati-Riboni, M., M. Kanwal, O. Bulgari, S. Meier, N. V. Priest, C. 
R. Burke, J. K. Kay, S. McDougall, M. D. Mitchell, C. G. Walker, 
M. Crookenden, A. Heiser, J. R. Roche, and J. J. Loor. 2016. Body 
condition score and plane of nutrition prepartum affect adipose 
tissue transcriptome regulators of metabolism and inflammation 
in grazing dairy cows during the transition period. J. Dairy Sci. 
99:758–770.
Ventto, L., H. Leskinen, P. Kairenius, T. Stefanski, A. R. Bayat, J. 
Vilkki, and K. J. Shingfield. 2017. Diet-induced milk fat depression 
is associated with alterations in ruminal biohydrogenation path-
ways and formation of novel fatty acid intermediates in lactating 
cows. Br. J. Nutr. 117:364–376.
von Soosten, D., U. Meyer, M. Piechotta, G. Flachowsky, and S. Dae-
nicke. 2012. Effect of conjugated linoleic acid supplementation 
on body composition, body fat mobilization, protein accretion, 
and energy utilization in early lactation dairy cows. J. Dairy Sci. 
95:1222–1239.
Wang, W., and M. Fromm. 2015. Sphingolipids are required for effi-
cient triacylglycerol loss in conjugated linoleic acid treated adipo-
cytes. PLoS One 10:e0119005.
Zened, A., A. Troegeler-Meynadier, T. Najar, and F. Enjalbert. 2012. 
Effects of oil and natural or synthetic vitamin E on ruminal and 
milk fatty acid profiles in cows receiving a high-starch diet. J. 
Dairy Sci. 95:5916–5926.
